Accesso libero

The Role of the Nephrologist in the Treatment and Prevention of Nephrolithiasis

, , , ,  e   
31 ago 2024
INFORMAZIONI SU QUESTO ARTICOLO

Cita
Scarica la copertina

Pharmacological substances used for kidney stone prevention

Agent Rationale Stone type
Alkaline citrates

Alkalinisation

Hypocitraturia

Inhibition of calcium oxalate crystallisation

Calcium oxalate

Uric acid

Cystine

Allopurinol

Hyperuricosuria

Hyperuricaemia

Calcium oxalate

Uric acid

Ammonium urate 2,8-Dihydroxyadenine

Calcium Enteric hyperoxaluria Calcium oxalate
Captopril

Cystinuria

Active decrease of urinary cystine levels

Cystine
Febuxostad

Hyperuricosuria

Hyperuricaemia

Calcium oxalate

Uric acid

L-methionine Urine acidification

Infection stones

Ammonium urate

Calcium phosphate

Magnesium

Isolated

Hypomagnesuria

Enteric hyperoxaluria

Calcium oxalate
Sodium bicarbonate

Alkalinisation

Hypocitraturia

Uric acid

Cystine

Pyridoxine Primary hyperoxaluria Calcium oxalate
Thiazide Hypercalciuria

Calcium oxalate

Calcium phosphate

Tiopronin Cystinuria Cystine

General preventive measures for kidney stone formation

Fluid intake Fluid amount: 2500–3000 ml
Water is the preferred fluid.
Diuresis: 2000–2500 ml/24 hours
Specific weight of urine: < 1,010 g/day
Nutritional advice for a balanced diet Balanced diet – avoid excessive intake of vitamin supplements
Increase intake of fibre and vegetables
Optimal calcium intake 1000–1200 g a day
Limited salt intake < 4–5 g/day
Limited animal protein intake: 800–1000 mg/day
Lifestyle advice Normal BMI
Adequate physical activity
Avoid excessive fluid loss
Reduce intake of alcohol
Reduce intake of calorie-containing fluids
Lingua:
Inglese
Frequenza di pubblicazione:
3 volte all'anno
Argomenti della rivista:
Medicina, Medicina clinica, Medicina interna, Cardiologia